|
Volumn 95, Issue 7, 2003, Pages 507-509
|
New study questions marketing of spiral CT scanning to consumers
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER LOCALIZATION;
CANCER MORTALITY;
CANCER SCREENING;
CLINICAL STUDY;
CLINICAL TRIAL;
COMPUTER SIMULATION;
CONSUMER;
COST EFFECTIVENESS ANALYSIS;
EARLY DIAGNOSIS;
EVIDENCE BASED MEDICINE;
HUMAN;
IMAGING SYSTEM;
INTERMETHOD COMPARISON;
LUNG CANCER;
MARKETING;
NOTE;
PRIORITY JOURNAL;
RADIODIAGNOSIS;
SPIRAL COMPUTER ASSISTED TOMOGRAPHY;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
ECONOMICS;
FINANCIAL MANAGEMENT;
HEALTH CARE COST;
HEALTH CARE ORGANIZATION;
LABORATORY DIAGNOSIS;
LUNG TUMOR;
MASS SCREENING;
METHODOLOGY;
MORTALITY;
QUALITY ADJUSTED LIFE YEAR;
RADIOGRAPHY;
RANDOMIZED CONTROLLED TRIAL;
SMOKING;
STANDARD;
STATISTICS;
SURVIVAL RATE;
THORAX RADIOGRAPHY;
UNITED STATES;
FALSE POSITIVE REACTIONS;
HEALTH CARE COSTS;
HUMANS;
LUNG NEOPLASMS;
MARKETING OF HEALTH SERVICES;
MASS CHEST X-RAY;
MASS SCREENING;
NATIONAL INSTITUTES OF HEALTH (U.S.);
QUALITY-ADJUSTED LIFE YEARS;
RANDOMIZED CONTROLLED TRIALS;
SMOKING;
SURVIVAL RATE;
TOMOGRAPHY, SPIRAL COMPUTED;
UNITED STATES;
|
EID: 0037413946
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/95.7.507 Document Type: Note |
Times cited : (3)
|
References (0)
|